77.5 B+

Humanin

Also known as: HN, Humanin-G

Strong Clinical Evidence Research Chemical
Research Evidence 90.0/100
Safety Profile 65.0/100

55 Clinical Trials

Unknown: 13 PHASE4: 1 PHASE3: 7 PHASE2: 8 PHASE1, PHASE2: 1 PHASE1: 2 NA: 22 EARLY_PHASE1: 1

Showing 5 of 55 trials.

20 Research Papers

Showing 5 of 20 papers by citation count.

FDA Data

Not FDA-Approved

Humanin has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.

Frequently Asked Questions

Is Humanin FDA approved?
No, Humanin has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has Humanin been studied in?
Humanin has been studied in 55 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Humanin?
Humanin has a CheckPeptides trust score of 77.5/100 (grade: B+). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026

Quick Facts

Classification
Mitochondria-derived peptide
Regulatory Status
N/A

Score Breakdown

Research Evidence 90.0/100
Safety Profile 65.0/100

Evidence Summary

Clinical Trials
55
Research Papers
20
Trust Score
77.5/100
Grade
B+

Compare Peptides

See how Humanin stacks up against similar peptides.

View Comparisons
← Browse all peptides